The invention relates to the use of [2-(3-methoxyphenyl)-cyclohexylmethyl]-dimethylamine and the metabolites thereof for producing a medicament that isused fortreating anxiety attacks or for producing an adjuvant to standardantidepressants. Alsodisclosed are methods for the treatment of anxiety attacks or depressions.